{"author_name":"Tatsu21","published":"2025-10-28 06:27:31","height":"190","type":"rich","categories":[],"author_url":"https://blog.hatena.ne.jp/Tatsu21/","provider_url":"https://hatena.blog","description":"Q: Preferred term for \u201cprogression-free survival\u201d A: \u201cProgression-free interval\u201d The time from when a Tx is started until that Tx is no longer controlling the cancer Q: Checkpoint inhibitor toxicity A: Autoimmune disease Checkpoint inhibitors: a type of cancer immunotherapy that works by blocking pr\u2026","version":"1.0","blog_title":"\u30ec\u30b8\u30c7\u30f3\u30c8\u30ce\u30fc\u30c8","title":"Oncology F","image_url":null,"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Ftatsu21.hatenablog.com%2Fentry%2F2025%2F10%2F28%2F062731\" title=\"Oncology F - \u30ec\u30b8\u30c7\u30f3\u30c8\u30ce\u30fc\u30c8\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","provider_name":"Hatena Blog","width":"100%","url":"https://tatsu21.hatenablog.com/entry/2025/10/28/062731","blog_url":"https://tatsu21.hatenablog.com/"}